Literature DB >> 10820349

Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence.

P Hillemanns1, H Weingandt, R Baumgartner, J Diebold, W Xiang, H Stepp.   

Abstract

BACKGROUND: Screening for cervical carcinoma and its precursors is based on cervical cytology and diagnostic colposcopy. Despite the decrease in the incidence of cervical carcinoma in countries with a good screening program, this rate of decline is leveling off. Known problems are false-negative rates of cytology and low specificity of colposcopy. This clinical study examined the diagnostic potential of porphyrin fluorescence in patients with cervical intraepithelial neoplasia Grade 1-3 (CIN 1-3).
METHODS: Sixty-eight women attending our colposcopy clinic underwent a gynecologic examination, including cytology, human papillomavirus (HPV) testing, and colposcopy. They received 10 mL 0.5% or 1.0% 5-aminolevulinic acid (5-ALA) topically. After 30-360 minutes, real-time image analysis was performed, and spectra were obtained from 685 sites.
RESULTS: Due to rapid photobleaching, 0.5% 5-ALA proved ineffective for fluorescence assessment. Using 1% 5-ALA, the authors found that fluorescence intensities correlated with incubation time; however, fluorescence contrast showed a maximum at 60-90 minutes (ratio 11:1). HPV DNA positive lesions showed significantly higher fluorescence. Fluorescence imaging after 60-90 minutes achieved similar sensitivity and specificity compared with colposcopy in detecting CIN with 94% and 51% versus 95% and 50%, respectively. However, the specificity was markedly improved by fluorescence spectroscopy, achieving 75%. The evaluation of spectral measurements revealed significantly higher values for CIN compared with normal tissue and for CIN 2/3 compared with CIN 1 (P < 0.001).
CONCLUSIONS: Using a time interval of 60-90 minutes after topical application of 1% 5-ALA, the authors observed specific porphyrin fluorescence of CIN. Fluorescence spectroscopy promises to become a valuable tool for the diagnosis of CIN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820349     DOI: 10.1002/(sici)1097-0142(20000515)88:10<2275::aid-cncr11>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Experimental validation of an inverse fluorescence Monte Carlo model to extract concentrations of metabolically relevant fluorophores from turbid phantoms and a murine tumor model.

Authors:  Chengbo Liu; Narasimhan Rajaram; Karthik Vishwanath; Tony Jiang; Gregory M Palmer; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2012-07       Impact factor: 3.170

3.  Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report.

Authors:  Peter Hillemanns; Jessica Reiff; Herbert Stepp; Philipp Soergel
Journal:  Lasers Med Sci       Date:  2007-01-09       Impact factor: 3.161

Review 4.  Recent advances in the prevention and treatment of skin cancer using photodynamic therapy.

Authors:  Baozhong Zhao; Yu-Ying He
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

5.  ALA (5-aminolevulinic acid)-induced protoporphyrin IX fluorescence in the endoscopic diagnostic and control of pharyngo-laryngeal cancer.

Authors:  Miklos Csanády; József G Kiss; László Iván; József Jóri; Jeno Czigner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-09-03       Impact factor: 2.503

6.  5-aminolevulinic-acid-based fluorescence spectroscopy and conventional colposcopy for in vivo detection of cervical pre-malignancy.

Authors:  Rasa Vansevičiūtė; Jonas Venius; Olga Žukovskaja; Daiva Kanopienė; Simona Letautienė; Ričardas Rotomskis
Journal:  BMC Womens Health       Date:  2015-04-17       Impact factor: 2.809

7.  A study of concentration changes of Protoporphyrin IX and Coproporphyrin III in mixed samples mimicking conditions inside cancer cells for Photodynamic Therapy.

Authors:  Rainer Landes; Alfredo Illanes; Daniela Goeppner; Harald Gollnick; Michael Friebe
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.